SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing significant downward pressure, with traders observing substantial liquidations and the asset struggling to hold key support levels. The community is actively debating whether broader macroeconomic concerns, political uncertainties like potential government shutdowns, and institutional manipulation are contributing to its underperformance compared to traditional safe-haven assets.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBAR is a hot topic, with the community highly focused on potential impacts from upcoming US "Clarity Act" legislative discussions. Investors are sharply divided, as some "stack" the token, citing its enterprise utility and institutional partnerships, while others express strong skepticism, labeling it a "turd" due to recent price action and broader market uncertainty. This ongoing debate reflects differing views on Hedera's long-term potential as a utility coin amidst volatile crypto conditions.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention following its expanded pipeline, including the acquisition of VLX-1005, and ongoing collaboration with Abbott for the pivotal Phase 3 trial of tecarfarin in anticoagulation. The community is actively discussing the substantial market opportunity for its novel therapies and the potential for volatility due to its ultra-low float, alongside prevalent skepticism regarding funding and perceived promotional bot activity.

Dogelon Mars

Dogelon Mars ($ELON) is currently trending amidst intense community debate, with many investors expressing deep frustration over its prolonged decline and perceived failure to deliver on promises like a "Great Burn" or "Metaverse." While a segment of holders clings to hope for a future rebound, often referencing broader crypto "supercycle" narratives, the prevalent sentiment points to it as a 'dead coin' with developers accused of dumping supply. Discussions frequently highlight its inability to follow broader market rallies, contrasting its performance with other meme coins and major cryptocurrencies.

Columbus Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was founded on January 18, 2024 and is headquartered in Singapore.

Columbus Acquisition Corp

Columbus Acquisition Corp (COLA) is gaining traction as its redemption deadline approaches, fueling community speculation around a potential low float scenario. Investors are discussing the squeeze potential from a reduced share count, especially with the impending merger with WISeSat, a company focused on the dynamic space and quantum security sector.

Perpetual Protocol

Perpetual Protocol (PERP) is trending amid high trading volume and a relatively low circulating supply, sparking intense community speculation about an imminent price surge. Traders are actively discussing chart patterns and expressing a strong conviction in its potential for a significant rebound, despite some frustration over its volatile price action compared to its historical highs.

Spring Valley Acquisition Corp. III is a blank check company. It was created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on March 12, 2025 an is headquartered in Dallas, TX.

Spring Valley Acquisition Corp III - Ordinary Shares - Class A

SVAC is generating significant buzz following its definitive business combination agreement with General Fusion, positioning it to become the first publicly traded pure-play nuclear fusion company. The community is highly optimistic about this long-term energy play, drawing comparisons to successful SPACs like SMR and OKLO, notably highlighting Jeff Bezos's backing and the Spring Valley team's prior success. Investors are actively discussing the groundbreaking potential of nuclear fusion technology and the perceived early entry opportunity into this transformative sector.

PAW Chain has launched the world’s first Layer 3-centric blockchain, enhancing scalability and inter-chain operability across networks. The roadmap features a decentralized exchange, merchant services, and a DAO, all optimized for high-volume, low-cost transactions. Leveraging smart contracts and EVM compatibility, PAW Chain is set to transform digital finance by providing secure, efficient solutions, allowing any project to go multi-chain, underscored by a community-driven governance model and rigorous security standards including regular security audits.

PAW CRYPTO is gaining significant attention as PAW Chain progresses with its Layer 3 blockchain architecture, focusing on unified liquidity across numerous networks and robust enterprise solutions. The community is actively discussing upcoming rebranding, a major network relaunch, and recent AMAs that highlight its potential to bridge Web2 companies to Web3 through quantum-safe subnets and a seamless user experience. Investors are bullish on its long-term vision, recognizing it as a foundational infrastructure project rather than a speculative asset.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as the U.S. government announced a significant $1.6 billion investment for a 10% stake, complemented by a separate private financing deal and a French government-backed facility, signaling a major push to secure critical mineral supply chains. The community is buzzing with excitement over the strategic importance of rare earths for national security and technology, anticipating a substantial upward revaluation and potential short squeeze, though some caution over dilution and deal specifics remains part of the active discussion.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing intense investor interest due to recent positive clinical updates for its glioblastoma trial, which demonstrated exceptional patient survival rates and immune restoration using chemo-free methods. This follows a groundbreaking Saudi FDA approval for ANKTIVA in both bladder and lung cancer, marking a significant global expansion. The community is buzzing about these advancements and awaiting further data on its therapeutic HPV vaccine, highlighting ANKTIVA's potential as a universal immune enhancer across multiple cancer types.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
